Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-glutamine for Generalized Anxiety Disorder
NCT04274114Phase 2Terminated
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Jan 2019
- Primary completion
- May 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of glutamine in generalized anxiety disorder (GAD), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Started Jan 2019; status: terminated.
02
Drugs
glutamine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT04274114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04274114.